ClearPoint Neuro (CLPT) Change in Cash (2011 - 2026)
ClearPoint Neuro (CLPT) reported Change in Cash of -$10.5 million for Q1 2026, down 35.51% on a YoY basis from -$16.2 million in Q1 2025, and down 221.99% sequentially from $8.6 million in Q4 2025.
ClearPoint Neuro (CLPT) Change in Cash (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Change in Cash data on file, last reported at -$10.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 35.51% year-over-year to -$10.5 million; the trailing twelve-month figure through Mar 2026 stood at $24.1 million (up 205.06% YoY), and the FY2025 full-year result was $26.9 million, up 985.01% from the prior year.
- Change in Cash eased to -$10.5 million in Q1 2026, from $8.6 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $29.3 million in Q2 2025 to a low of -$26.1 million in Q2 2022.
- A 5-year average of -$1.0 million and a median of -$2.5 million in 2024 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash sank 683.86% in 2022 and soared 1269.62% in 2025, its largest moves.
- Tracing CLPT's Change in Cash over 5 years: stood at $8.9 million in 2022, then tumbled by 113.5% to -$1.2 million in 2023, then declined by 22.21% to -$1.5 million in 2024, then jumped by 683.53% to $8.6 million in 2025, then slumped by 221.99% to -$10.5 million in 2026.
- Business Quant data shows CLPT's Change in Cash at -$10.5 million in Q1 2026, $8.6 million in Q4 2025, and -$3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -10.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.46 Mn |
| Dec 31, 2025 | 8.57 Mn |
| Sep 30, 2025 | -3.32 Mn |
| Jun 30, 2025 | 29.33 Mn |
| Mar 31, 2025 | -7.72 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | -11.27 Mn |
| Jun 30, 2024 | -2.51 Mn |
| Mar 31, 2024 | 12.21 Mn |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | -2.12 Mn |
| Jun 30, 2023 | 4.67 Mn |
| Mar 31, 2023 | -5.82 Mn |
| Dec 31, 2022 | 8.90 Mn |
| Sep 30, 2022 | -4.81 Mn |
| Jun 30, 2022 | -26.13 Mn |
| Mar 31, 2022 | -4.45 Mn |
| Dec 31, 2021 | -3.54 Mn |
| Sep 30, 2021 | -3.87 Mn |
| Jun 30, 2021 | -3.33 Mn |